Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Alcon Inc. stock logo
ALC
Alcon
$82.01
+0.7%
$82.59
$69.44
$88.23
$40.44B0.92886,023 shs1.19 million shs
National Vision Holdings, Inc. stock logo
EYE
National Vision
$14.76
-2.6%
$20.24
$13.71
$27.02
$1.43B1.471.00 million shs2.39 million shs
Luxottica Group SpA stock logo
LUXTY
Luxottica Group
$55.80
+0.4%
$55.80
$49.83
$69.03
$27.07B0.2714,259 shs2,900 shs
STAAR Surgical stock logo
STAA
STAAR Surgical
$42.35
-1.2%
$42.37
$26.66
$67.36
$2.26B0.8539,145 shs440,889 shs
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Alcon Inc. stock logo
ALC
Alcon
+1.40%+3.88%-1.46%+5.54%+1.04%
National Vision Holdings, Inc. stock logo
EYE
National Vision
+1.68%-13.77%-26.53%-24.40%-33.35%
Luxottica Group SpA stock logo
LUXTY
Luxottica Group
0.00%0.00%0.00%0.00%0.00%
STAAR Surgical stock logo
STAA
STAAR Surgical
+4.49%-5.88%-17.97%+42.11%-36.62%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Alcon Inc. stock logo
ALC
Alcon
3.6391 of 5 stars
3.34.00.80.02.40.82.5
National Vision Holdings, Inc. stock logo
EYE
National Vision
4.104 of 5 stars
3.03.00.03.33.70.01.9
Luxottica Group SpA stock logo
LUXTY
Luxottica Group
N/AN/AN/AN/AN/AN/AN/AN/A
STAAR Surgical stock logo
STAA
STAAR Surgical
4.8341 of 5 stars
3.23.00.04.12.43.33.1

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Alcon Inc. stock logo
ALC
Alcon
2.64
Moderate Buy$91.2211.23% Upside
National Vision Holdings, Inc. stock logo
EYE
National Vision
2.00
Hold$21.0042.28% Upside
Luxottica Group SpA stock logo
LUXTY
Luxottica Group
N/AN/AN/AN/A
STAAR Surgical stock logo
STAA
STAAR Surgical
2.40
Hold$47.1311.28% Upside

Current Analyst Ratings

Latest ALC, LUXTY, EYE, and STAA Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/10/2024
National Vision Holdings, Inc. stock logo
EYE
National Vision
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$19.00 ➝ $16.00
5/8/2024
STAAR Surgical stock logo
STAA
STAAR Surgical
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold
5/8/2024
STAAR Surgical stock logo
STAA
STAAR Surgical
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$46.00 ➝ $43.00
5/8/2024
STAAR Surgical stock logo
STAA
STAAR Surgical
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$33.00 ➝ $40.00
5/8/2024
STAAR Surgical stock logo
STAA
STAAR Surgical
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$53.00 ➝ $55.00
4/22/2024
Alcon Inc. stock logo
ALC
Alcon
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$95.00 ➝ $95.00
4/11/2024
STAAR Surgical stock logo
STAA
STAAR Surgical
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$45.00 ➝ $53.00
4/10/2024
Alcon Inc. stock logo
ALC
Alcon
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$100.00
4/8/2024
STAAR Surgical stock logo
STAA
STAAR Surgical
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$32.00 ➝ $46.00
4/4/2024
STAAR Surgical stock logo
STAA
STAAR Surgical
William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeMarket Perform ➝ Outperform
4/4/2024
STAAR Surgical stock logo
STAA
STAAR Surgical
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold
(Data available from 5/10/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Alcon Inc. stock logo
ALC
Alcon
$9.46B4.28$5.41 per share15.17$41.83 per share1.96
National Vision Holdings, Inc. stock logo
EYE
National Vision
$2.13B0.54$1.45 per share10.17$10.60 per share1.39
Luxottica Group SpA stock logo
LUXTY
Luxottica Group
$10.34B2.62$3.57 per share15.62$13.74 per share4.06
STAAR Surgical stock logo
STAA
STAAR Surgical
$322.42M6.45$0.68 per share62.18$7.91 per share5.35

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Alcon Inc. stock logo
ALC
Alcon
$974M$1.9641.8423.632.0410.30%6.75%4.63%5/14/2024 (Estimated)
National Vision Holdings, Inc. stock logo
EYE
National Vision
-$65.90M-$0.85N/A31.404.03-3.10%3.69%1.41%8/8/2024 (Estimated)
Luxottica Group SpA stock logo
LUXTY
Luxottica Group
$1.17B$2.2924.37N/AN/AN/AN/AN/A
STAAR Surgical stock logo
STAA
STAAR Surgical
$21.35M$0.4398.4983.04N/A6.62%8.73%6.99%8/7/2024 (Estimated)

Latest ALC, LUXTY, EYE, and STAA Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2024Q1 24
STAAR Surgical stock logo
STAA
STAAR Surgical
$0.05-$0.07-$0.12-$0.07$75.34 million$77.40 million    
2/27/2024Q4 2023
Alcon Inc. stock logo
ALC
Alcon
$0.68$0.70+$0.02$0.54$2.34 billion$2.33 billion  
2/27/202412/31/2023
National Vision Holdings, Inc. stock logo
EYE
National Vision
-$0.09-$0.02+$0.07$0.06$499.49 million$506.40 million      
2/26/2024Q4 23
STAAR Surgical stock logo
STAA
STAAR Surgical
$0.17$0.16-$0.01$0.32$75.94 million$76.27 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Alcon Inc. stock logo
ALC
Alcon
N/AN/AN/AN/A3 Years
National Vision Holdings, Inc. stock logo
EYE
National Vision
N/AN/AN/AN/AN/A
Luxottica Group SpA stock logo
LUXTY
Luxottica Group
$0.911.63%N/A39.74%N/A
STAAR Surgical stock logo
STAA
STAAR Surgical
N/AN/AN/AN/AN/A

Latest ALC, LUXTY, EYE, and STAA Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/10/2024
Alcon Inc. stock logo
ALC
Alcon
$0.15600.21%5/14/20245/15/20245/16/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Alcon Inc. stock logo
ALC
Alcon
0.22
2.28
1.34
National Vision Holdings, Inc. stock logo
EYE
National Vision
0.54
1.00
0.70
Luxottica Group SpA stock logo
LUXTY
Luxottica Group
0.19
1.18
0.88
STAAR Surgical stock logo
STAA
STAAR Surgical
N/A
5.62
5.08

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Alcon Inc. stock logo
ALC
Alcon
53.86%
National Vision Holdings, Inc. stock logo
EYE
National Vision
N/A
Luxottica Group SpA stock logo
LUXTY
Luxottica Group
0.09%
STAAR Surgical stock logo
STAA
STAAR Surgical
96.70%

Insider Ownership

CompanyInsider Ownership
Alcon Inc. stock logo
ALC
Alcon
N/A
National Vision Holdings, Inc. stock logo
EYE
National Vision
2.10%
Luxottica Group SpA stock logo
LUXTY
Luxottica Group
75.00%
STAAR Surgical stock logo
STAA
STAAR Surgical
1.00%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Alcon Inc. stock logo
ALC
Alcon
25,000493.10 millionN/AOptionable
National Vision Holdings, Inc. stock logo
EYE
National Vision
13,99878.31 million76.67 millionOptionable
Luxottica Group SpA stock logo
LUXTY
Luxottica Group
85,150485.06 millionN/ANot Optionable
STAAR Surgical stock logo
STAA
STAAR Surgical
1,11549.13 million48.64 millionOptionable

LUXTY, ALC, EYE, and STAA Headlines

SourceHeadline
STAAR Surgical (NASDAQ:STAA) Rating Reiterated by Needham & Company LLCSTAAR Surgical (NASDAQ:STAA) Rating Reiterated by Needham & Company LLC
americanbankingnews.com - May 10 at 5:26 AM
Geneva Capital Management LLC Lowers Position in STAAR Surgical (NASDAQ:STAA)Geneva Capital Management LLC Lowers Position in STAAR Surgical (NASDAQ:STAA)
marketbeat.com - May 9 at 10:01 PM
STAAR Surgical First Quarter 2024 Earnings: Beats ExpectationsSTAAR Surgical First Quarter 2024 Earnings: Beats Expectations
finance.yahoo.com - May 9 at 11:29 AM
STAAR Surgical (NASDAQ:STAA)  Shares Down 8.7%  on Disappointing EarningsSTAAR Surgical (NASDAQ:STAA) Shares Down 8.7% on Disappointing Earnings
americanbankingnews.com - May 9 at 2:18 AM
Staar Surgical Hold Rating Maintained Amid Modest Growth and Strategic CautionStaar Surgical Hold Rating Maintained Amid Modest Growth and Strategic Caution
markets.businessinsider.com - May 9 at 1:28 AM
What 7 Analyst Ratings Have To Say About Staar SurgicalWhat 7 Analyst Ratings Have To Say About Staar Surgical
markets.businessinsider.com - May 8 at 8:28 PM
Staar Surgical: Q1 Earnings SnapshotStaar Surgical: Q1 Earnings Snapshot
houstonchronicle.com - May 8 at 3:27 PM
STAAR Surgical Company is about to announce earnings — heres what Wall Street expectsSTAAR Surgical Company is about to announce earnings — here's what Wall Street expects
markets.businessinsider.com - May 8 at 3:27 PM
STAAR Surgical Company (NASDAQ:STAA) Q1 2024 Earnings Call TranscriptSTAAR Surgical Company (NASDAQ:STAA) Q1 2024 Earnings Call Transcript
finance.yahoo.com - May 8 at 3:27 PM
STAAR Surgical (NASDAQ:STAA) Price Target Cut to $43.00STAAR Surgical (NASDAQ:STAA) Price Target Cut to $43.00
marketbeat.com - May 8 at 2:34 PM
STAAR Surgical (NASDAQ:STAA) Price Target Raised to $40.00STAAR Surgical (NASDAQ:STAA) Price Target Raised to $40.00
marketbeat.com - May 8 at 1:09 PM
STAAR Surgical (NASDAQ:STAA) Trading Down 8.7% on Disappointing EarningsSTAAR Surgical (NASDAQ:STAA) Trading Down 8.7% on Disappointing Earnings
marketbeat.com - May 8 at 11:00 AM
Staar Surgical Co (STAA) Q1 2024 Earnings Call Transcript Highlights: Navigating Growth Amid ...Staar Surgical Co (STAA) Q1 2024 Earnings Call Transcript Highlights: Navigating Growth Amid ...
finance.yahoo.com - May 8 at 5:20 AM
Staar Surgical (STAA) Reports Q1 Earnings: What Key Metrics Have to SayStaar Surgical (STAA) Reports Q1 Earnings: What Key Metrics Have to Say
zacks.com - May 7 at 8:30 PM
Staar Surgical Co Reports Q1 2024 Results: Misses Earnings Projections Despite Revenue GrowthStaar Surgical Co Reports Q1 2024 Results: Misses Earnings Projections Despite Revenue Growth
finance.yahoo.com - May 7 at 7:19 PM
STAAR Surgical (NASDAQ:STAA) Releases Quarterly  Earnings Results, Misses Expectations By $0.12 EPSSTAAR Surgical (NASDAQ:STAA) Releases Quarterly Earnings Results, Misses Expectations By $0.12 EPS
marketbeat.com - May 7 at 6:33 PM
STAAR Surgical Announces Milestone Strategic Agreement in U.S. with IQ Laser VisionSTAAR Surgical Announces Milestone Strategic Agreement in U.S. with IQ Laser Vision
businesswire.com - May 7 at 4:01 PM
Staar Surgical Poised for Growth in Refractive Surgery Market, Maintains Buy RatingStaar Surgical Poised for Growth in Refractive Surgery Market, Maintains Buy Rating
markets.businessinsider.com - May 7 at 8:12 AM
Wall Streets Insights Into Key Metrics Ahead of Staar Surgical (STAA) Q1 EarningsWall Street's Insights Into Key Metrics Ahead of Staar Surgical (STAA) Q1 Earnings
zacks.com - May 6 at 10:21 AM
STAAR Surgical (STAA) to Release Earnings on TuesdaySTAAR Surgical (STAA) to Release Earnings on Tuesday
americanbankingnews.com - May 5 at 6:24 AM
STAAR Surgical Companys (NASDAQ:STAA) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?STAAR Surgical Company's (NASDAQ:STAA) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?
finance.yahoo.com - May 1 at 5:34 PM
STAAR Surgical Strengthens Leadership Team with Appointments of Nancy Sabin as Chief Marketing Officer and Nathaniel Sisitsky as General CounselSTAAR Surgical Strengthens Leadership Team with Appointments of Nancy Sabin as Chief Marketing Officer and Nathaniel Sisitsky as General Counsel
businesswire.com - May 1 at 7:00 AM
STAAR Surgical (NASDAQ:STAA) Given Average Recommendation of "Hold" by AnalystsSTAAR Surgical (NASDAQ:STAA) Given Average Recommendation of "Hold" by Analysts
americanbankingnews.com - May 1 at 2:54 AM
STAAR Surgical (STAA) to Release Quarterly Earnings on TuesdaySTAAR Surgical (STAA) to Release Quarterly Earnings on Tuesday
marketbeat.com - April 30 at 1:21 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Alcon logo

Alcon

NYSE:ALC
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, ARGOS biometer, LuxOR surgical ophthalmic microscope, SMARTCATARACT health platform, NGENUITY 3D visualization system, Verion reference unit and Verion digital marker, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantable products, including AcrySof IQ products, such as monofocal IOLs and advanced technology IOLs for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
National Vision logo

National Vision

NASDAQ:EYE
National Vision Holdings, Inc., through its subsidiaries, operates as an optical retailer in the United States. The company operates in two segments, Owned & Host and Legacy. It offers eyeglasses and contact lenses, and optical accessory products; provides eye exams through its America's Best, Eyeglass World, Vista Optical, Fred Meyer, and Vista Optical military, as well as Vision Center branded stores; and offers health maintenance organization and optometric services. National Vision Holdings, Inc. was founded in 1990 and is headquartered in Duluth, Georgia.
Luxottica Group logo

Luxottica Group

OTCMKTS:LUXTY
Luxottica Group S.p.A., together with its subsidiaries, provides fashion, luxury, sports, and performance eyewear worldwide. It operates through two segments, Manufacturing and Wholesale Distribution, and Retail Distribution. The Manufacturing and Wholesale Distribution segment engages in the design, manufacture, distribution, and marketing of proprietary and designer lines of prescription frames and sunglasses. This segment offers its products under proprietary brands, such as Ray-Ban, Oakley, Persol, Oliver Peoples, Alain Mikli, Arnette, and Vogue Eyewear; and licensed brands, including Giorgio Armani, Emporio Armani, Armani Exchange, Brooks Brothers, Burberry, Bulgari, Chanel, Coach, Dolce&Gabbana, DKNY, Michael Kors, Paul Smith Spectacles, Prada, Miu Miu, Ralph Lauren, Polo Ralph Lauren, Ralph, Starck Eyes, Tiffany & Co, Tory Burch, Valentino, Versace, and Ferrari. The Retail Distribution segment operates prescription eyewear stores primarily under its retail brands, including LensCrafters, Sunglass Hut, Pearle Vision, OPSM, Laubman & Pank, GMO, David Clulow, Salmoiraghi & Viganò, Ray-Ban, Oakley and Vault, Oliver Peoples, Alain Mikli, Ilori Optical, and Optical Shop of Aspen; and licensed brands, such as Sears Optical and Target Optical. As of December 31, 2017, it operated approximately 9,000 stores. The company was founded in 1961 and is headquartered in Milan, Italy. As of October 1, 2018, Luxottica Group S.p.A. operates as a subsidiary of EssilorLuxottica.
STAAR Surgical logo

STAAR Surgical

NASDAQ:STAA
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.